Macrocyclic serine protease inhibitors
US8093379B2 · kind B2 · utility
7Cited by
64References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 18, 2009 |
| Grant date | Jan 10, 2012 |
| Priority date | — |
| Expiry date | May 20, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula I, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.